These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 36930084)

  • 1. An integrative pan-cancer analysis illustrating the key role of LRP11 in cervical cancer.
    Gu F; Xu F; Pan Z; Shi L; Yu J; Song F; Huang S; Sun M
    Medicine (Baltimore); 2023 Mar; 102(11):e33201. PubMed ID: 36930084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis on clinical significance and therapeutic targets of LDL receptor related protein 11 (LRP11) in liver hepatocellular carcinoma.
    Yoo W; Kim AK; Kook HU; Noh K
    Front Pharmacol; 2024; 15():1338929. PubMed ID: 38425648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of low density lipoprotein receptor-related protein 11 as a tumor promoter in cervical cancer.
    Wang Y; Han S; You X; Shi X; Liu L; Sun Y; Ma Y; Qian Q; Liu H; Cui B; Zhang Y
    Cancer Manag Res; 2019; 11():8081-8093. PubMed ID: 31507330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and clinical value of LRP11, FUBP1 and TET1 in cervical cancer.
    Zhao X; Li S; Wen J; Li Y
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):80-84. PubMed ID: 37715422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX13-mediated transcription of LRP11 enhances malignant properties of tumor cells and CD8
    Yang T; Dong Y; Wang G; Guan X
    Cell Signal; 2024 Dec; 124():111383. PubMed ID: 39243917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
    BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer.
    Huang Y; You M; Wu Q; Zhu W; Guo F; Lin W
    Ann Clin Lab Sci; 2022 Nov; 52(6):904-917. PubMed ID: 36564070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.
    Li H; Zhang Y; Zheng S
    Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP11 activates β-catenin to induce PD-L1 expression in prostate cancer.
    Gan S; Ye J; Li J; Hu C; Wang J; Xu D; Pan X; Chu C; Chu J; Zhang J; Zheng J; Zhang X; Xu J; Zhang H; Qu F; Cui X
    J Drug Target; 2020 Jun; 28(5):508-515. PubMed ID: 31865764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
    Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
    PeerJ; 2022; 10():e14432. PubMed ID: 36518297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer.
    Chen X; Xie L; Qiao K; Zhu X; Ren J; Tan Y
    Aging (Albany NY); 2023 Jan; 15(3):689-704. PubMed ID: 36750200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
    Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
    Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.
    Liu C; Zhang W; Zhou X; Liu L
    Front Immunol; 2022; 13():983490. PubMed ID: 36618420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment.
    Yi C; Yang J; Zhang T; Xie S; Li W; Qin L; Chen D
    Clin Transl Oncol; 2023 Aug; 25(8):2569-2586. PubMed ID: 37022517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer.
    Xu F; Zou C; Gao Y; Shen J; Liu T; He Q; Li S; Xu S
    Front Immunol; 2022; 13():930488. PubMed ID: 36091054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.